Search Results

You are looking at 41 - 50 of 384 items for :

  • "early detection" x
  • Refine by Access: Content accessible to Me x
Clear All
Full access

Factors Associated With Detection and Survival of T1 Hepatocellular Carcinoma in the United States: National Cancer Database Analysis

Ju Dong Yang, Michael Luu, Amit G. Singal, Mazen Noureddin, Alexander Kuo, Walid S. Ayoub, Vinay Sundaram, Honore Kotler, Irene K. Kim, Tsuyoshi Todo, Georgios Voidonikolas, Todd V. Brennan, Kambiz Kosari, Andrew S. Klein, Andrew Hendifar, Shelly C. Lu, Nicholas N. Nissen, and Jun Gong

medical facility was strongly associated with very early detection: patients seen at an academic medical center had a 3.5-fold increased likelihood of having T1 HCC compared with those seen at community programs. Table 2. Factors Associated With Detection

Full access

Maintenance Therapy With Tyrosine Kinase Inhibitors After Transplant in Patients With Chronic Myeloid Leukemia

Merav Bar and Jerald Radich

emerged—the risk associated with BCR-ABL positivity is very high in T-cell-depleted transplant, and the prognostic significance of BCR-ABL positivity is less after a longer period after transplantation. 26 , 27 The potential of early detection of BCR

Full access

Impact of Provider Imaging Practices on Survival Outcomes in Advanced Ovarian Cancer

Angela K. Green, Deborah Korenstein, Carol Aghajanian, Brooke Barrow, Michael Curry, and Roisin E. O’Cearbhaill

the evaluation of new symptoms, in the presence of an increasing CA-125 level, or for routine scheduled surveillance in the absence of either symptoms or a change in CA-125 level. Routine surveillance imaging may allow for earlier detection of

Full access

NCCN Policy Summit: Cancer Across Geography

Sean T. McCarson, Alyssa Schatz, Victoria Hood, Ashley Orr, Aaron Bailey, Jesse Plascak, Ursa Brown-Glaberman, Elisa M. Rodriguez, Taneal Carter, and Crystal Denlinger

. Addressing Cancer Disparities Across Geography Geographic location of a patient directly impacts access to care, including preventative screenings and early detection. Moreover, many additional SDoHs, including a patient’s self-identified race, ethnicity

Full access

Role of Routine Imaging in Lymphoma

Nina D. Wagner-Johnston and Nancy L. Bartlett

mostly retrospective series precludes an overall assessment of whether early detection of relapse may impact outcome. Analyzing large databases may address these concerns. Ultimately, randomized studies are needed to answer questions regarding the role of

Full access

CLO19-052: Incidence of Ribociclib-Associated Cardiac Conduction Abnormalities in Patients With Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer: A Combined Analysis of 3 Phase III Randomized Controlled Trials

Kyaw Z. Thein, Somedeb Ball, Sriman Swarup, Anita Sultan, Myo H. Zaw, Lukman Tijani, Sanjay Awasthi, Fred Hardwicke, and Catherine Jones

dysfunction due to prior cardiotoxic chemotherapies. In our meta-analysis, ribociclib was associated with significantly higher risk of QTc prolongation and the resultant dosing inconsistencies and discontinuation. Early detection of this potential adverse

Full access

HSR19-079: Disparities in Accessing Screening Mammography: Opportunities for Improving Diagnostic Outcomes

Nila Alsheik, Zhaohui Su, Anna Lafontant, Gregory Donadio, Kathleen Troeger, Scott Pohlman, Melinda Talley, Vandana Menon, and Emily Conant

Introduction: Screening mammography is a key component of secondary prevention programs targeting reductions in breast cancer mortality. The early detection of cancers facilitates treatment at a more curable, locoregionally limited stage. We

Full access

EPR19-067: Effectiveness of Breast Cancer Awareness Campaign on Internet Search Activity Compared to Other Gynecological Malignancies

Akriti Gupta Jain, Abdul Kareem Khan, Ranjeet Kumar, Mohammed Wazir, Syed Askari Hasan, and Umair Majeed

cancer awareness month (CAM) in 1985. Cervical (CC) and ovarian cancers (OC) are associated with a high mortality as well and have awareness months dedicated to them. The aim of these awareness drives is to change public attitude and help in early

Full access

CLO19-031: Immune Checkpoint Inhibitors: Optimization of Pharmacy Services in Toxicity Management

Olivia G. Fahey, Elizabeth N. Dow, Jennifer K. Piccolo, and Ticiana A. Leal

Background: Use of immune checkpoint inhibitors (ICPi) in oncology continues to rapidly expand. ICPis have a unique toxicity profile and can lead to immune related adverse events (irAEs), some serious and potentially life-threatening. Early

Full access

QIM19-124: Does Virtual Navigation Improve Care Continuity and Compliance in Patients With Early Stage Colon Cancer?

Dayna Crawford, Brook Blackmore, Jeremy Ortega, and Erica Williams

Society Facts and Figures 2018). Early detection is increasing with nearly 45% of colon cancers diagnosed as stage I/II (Sarah Cannon Cancer Registry 2015). Treatment for early stage I/II colon cancer patients usually involves surgery then surveillance. On